China's gastric cancer and other cancer treatments are moving toward "precise medical care" June 29, 2015 Source: Xinhuanet Xinhuanet June 28th news (Liu Ying) Precision medicine is rapidly infiltrating into various professional fields of clinical medicine. On June 27th, at the Tenth National Conference on Gastric Cancer and the Third Sunshine Great Wall Oncology Conference, the concept of precision medicine was “continuously implementedâ€. Professor Ji Jiafu, chairman of the China Anti-Cancer Association Gastric Cancer Professional Committee and dean of the Peking University Cancer Hospital, pointed out that in recent years, due to the lack of sufficient models and analytical capabilities in cancer targeted therapy and medical research and development, blind clinical treatment, blind Research has wasted a lot of financial and material resources. The implementation of cancer precision medicine, the establishment of a big data platform, the analysis of shared genetic data, biological samples, living information and all electronic health information, in order to provide cancer patients with the most accurate treatment options, treatment drugs and related clinical experimental information, Let patients, doctors, and society benefit. It is reported that the conference is sponsored by the China Anti-Cancer Association Gastric Cancer Professional Committee and Peking University Cancer Hospital. It covers the fields of diagnosis, treatment and research of gastric cancer and neuroendocrine tumors. Professor Sun Yan, Senior Fellow of the Chinese Academy of Engineering, and the Chinese Medical Association Surgery Branch Academician Zhao Yupei, President of the Chinese Medical Association Association of Surgeons, Professor Wang Shan, Secretary-General of the China Association for Anti-Cancer, Wang Wei, and many medical experts from domestic and international gastric cancer and related fields, jointly carried out research on cancer prevention, especially in the field of gastric cancer. In-depth exchanges and discussions. In his opening speech, Professor Ji Jiafu said that as a follow-up scientific conference held after ASCO and the International Conference on Gastric Cancer (IGCC), the conference aims to further improve the standardization of diagnosis and treatment of gastric cancer in China, promote multidisciplinary collaboration, and promote the development of translational medicine. More useful attempts will be made to strengthen international exchanges and cooperation. Academician Sun Yan said that gastric cancer is one of the most common malignant tumors in the world and ranks third among the causes of death among residents. "We have standardized the diagnosis and treatment as one of the main ways to solve the tumor problem in the past ten years, and we have introduced it since 2006. The US NCCN guidelines have been developed in Chinese, and some of their contents have also been included in the original English guide. The National Health and Family Planning Commission also attaches great importance to the standardization and preparation of guidelines, because the promotion of medical treatment standards can improve the level of medical staff across the country. To provide patients with 'latest and best choices', so that most patients benefit. There are many patients with pre-cancerous chronic atrophic gastritis in China. We have done clinical research 20 years ago, by strengthening Chinese medicine and killing Helicobacter pylori. Most of these patients are cured. Therefore, I believe that through the improvement of dietary habits and treatment of chronic atrophic gastritis, the incidence of gastric cancer will be significantly reduced." Su Xiangqian, deputy dean of Peking University Cancer Hospital, said that the current Chinese gastric cancer is mainly based on advanced gastric cancer, and whether the patient can receive radical surgery is the most important. Since 2008, Professor Ji Jiafu led the national standardization operation of gastric cancer, the overall level of radical surgery for gastric cancer in China has been greatly improved, but overall, there are still regional imbalances, and standardized gastric cancer surgery in some areas. The penetration rate is low. In this conference on gastric cancer, the Chinese Society of Anti-Cancer Association of Gastric Cancer Professional Committee held the "Sensor's Consensus on Gastric Cancer Operation and Digestive Tract Reconstruction", aiming to further promote and refine the standardized surgical treatment of gastric cancer in the country, and strive to make gastric cancer in different regions of China. The level of radical surgery tends to be consistent, which benefits more patients. Jiangsu Tiera Biotechnology Co., Ltd , https://www.tierabio.com